Acute phase reactant proteins as aids to monitoring disease.
The plasma acute phase reactant proteins are a group consisting mainly of glycosialated proteins, whose levels rise in response to a wide variety of injuries. This review discusses how by considering several APRPs coincidentally the pattern of change can have a discriminant function which can be used alone or to enhance other biochemical tests, especially in the monitoring of disease.
D000328:Adult; D001798:Blood Proteins / Q000032:analysis* / Q000096:biosynthesis; D002097:C-Reactive Protein / Q000502:physiology; D002918:Chymotrypsin / Q000037:antagonists & inhibitors / Q000502:physiology; D005260:Female; D006023:Glycoproteins / Q000096:biosynthesis / Q000097:blood*; D006801:Humans; D007249:Inflammation / Q000097:blood; D007938:Leukemia / Q000097:blood; D007962:Leukocytes / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008175:Lung Neoplasms / Q000097:blood; D008223:Lymphoma / Q000097:blood; D009336:Necrosis / Q000097:blood; D009369:Neoplasms / Q000097:blood; D009961:Orosomucoid / Q000502:physiology; D011480:Protease Inhibitors / Q000502:physiology; D013514:Surgical Procedures, Operative; D014361:Trypsin Inhibitors / Q000502:physiology; D014565:Urogenital Neoplasms / Q000097:blood; D000514:alpha 1-Antichymotrypsin
D001798:Blood Proteins; D006023:Glycoproteins; D009961:Orosomucoid; D011480:Protease Inhibitors; D014361:Trypsin Inhibitors; D000514:alpha 1-Antichymotrypsin; D002097:C-Reactive Protein; D002918:Chymotrypsin